From evidence-based medicine to guidelines and recommendations: a long and winding road. by Moore, R, Derry, S, Aldington, D

Amitriptyline for neuropathic pain and fibromyalgia in adults. by Moore, R, Derry, S, Aldington, D, Cole, P, Wiffen, P

Response to palmer. by Moore, A, McQuay, H, Wiffen, P, Derry, S, Straube, S, Eccleston, C, Bell, R, Aldington, D, Phillips, C

Clinical effectiveness: an approach to clinical trial design more relevant to clinical practice, acknowledging the importance of individual differences. by Moore, R, Derry, S, McQuay, H, Straube, S, Aldington, D, Wiffen, P, Bell, R, Kalso, E, Rowbotham, M

Response to Palmer by Moore, A, McQuay, H, Wiffen, P, Derry, S, Straube, S, Eccleston, C, Bell, R, Aldington, D, Phillips, C

Antiepileptic drugs for neuropathic pain and fibromyalgia - an overview of Cochrane reviews. by Wiffen, P, Derry, S, Moore, R, Aldington, D, Cole, P, Rice, A, Lunn, M, Hamunen, K, Haanpaa, M, Kalso, E

Estimate at your peril: imputation methods for patient withdrawal can bias efficacy outcomes in chronic pain trials using responder analyses. by Moore, R, Straube, S, Eccleston, C, Derry, S, Aldington, D, Wiffen, P, Bell, R, Hamunen, K, Phillips, C, McQuay, H

Estimate at your peril: imputation methods for patient withdrawal can bias efficacy outcomes in chronic pain trials using responder analyses. by Moore, R, Straube, S, Eccleston, C, Derry, S, Aldington, D, Wiffen, P, Bell, R, Hamunen, K, Phillips, C, McQuay, H